101 IL-6 inhibitors in hospitalised COVID-19 patients 5 Demographics Patients in the 8 mg/kg and fixed dose group were slightly younger than the low dose tocilizumab and sarilumab groups (Table 1). Most deaths occurred in the sarilumab and low dose tocilizumab group. From the patients who died, the 8 mg/kg group had the ICU as location of death more often than the other groups. Total in-hospital mortality was 26.7%.
RkJQdWJsaXNoZXIy MTk4NDMw